A 63-year-old female with a past medical history of hepatitis C and cirrhosis presented to the emergency department with a four-month history of increased swelling and tenderness to the right clavicle. The patient was afebrile with a firm, warm area measuring 6 cm x 4.5 cm x 2 cm, located over the medial right clavicle. The patient had a remote history of minor trauma that resulted in no fractures and required no interventions. She was diagnosed with sternoclavicular (SC) septic arthritis, with underlying osteomyelitis of the clavicle and sternum noted on plain radiographs and confirmed by computed tomography (CT).
Septic arthritis of the SC joint accounts for only 1% of all septic arthritis in the general population, but up to 17% in intravenous (IV) drug users. Common risk factors include IV drug use, distant site of infection, diabetes mellitus, and thoracic central venous line (CVL) placement. Less common predisposing conditions include minor trauma, cellulitis, cirrhosis, and immunocompromised states. Unlike the acute presentation of other septic joints, SC septic arthritis usually develops more slowly over 14 days. 1, 2 Patients suspected of having SC joint septic arthritis require either CT (83% sensitive) or magnetic resonance imaging (nearly 100% sensitive) to identify SC joint infections. 2 Blood and wound cultures guide antibiotic treatments; wound cultures may be obtained by simple incision and drainage, but usually require CT-guided needle aspiration. 3, 4 Patients with radiologic evidence of SC joint infection should be treated aggressively with IV antistaphylococcal antibiotics, based on local sensitivities. Gram-negative coverage should be added in IV drug users, immunocompromised, and patients with CVL infections. 3 Antibiotic coverage should then be tailored based on blood and aspiration cultures of the affected SC joint. The majority of SC joint infections will require surgical debridement. 
